GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, today announced a multi-target strategic alliance with GSK to discover and ...

For the first time, researchers at Phoenix's Barrow Neurological Institute have collected and displayed together the ...

Life sciences venture capitalist Vesalius Biocapital has raised 120 million euros in funding, focusing on investment in digital health as well as biotechs. The fund Vesalius Biocapital III was ...

Six centuries later, the Renaissance-era anatomist Vesalius sketched a cross-section of the orb—with some errors. But eyes themselves are imperfect: Just one fault could cause the whole organ to ...

Here are today's five things you need to know, including a Ground Round comeback, employer confidence and JFK auction items you can own.

A few individuals, such as Andreas Vesalius, Ambroise Paré and William Harvey, made particularly important contributions to medical knowledge during the 16th and 17th centuries. An illustration ...

Haw, Stephen G. 2023. Nutmeg and the Identity of Chinese Rou doukou. Acta Orientalia Academiae Scientiarum Hungaricae, Vol. 76, Issue. 3, p. 373.